MedTrace Logo

MyProstateScore Equivalency With and Without DRE

NCT05700370 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2023-01-26

No results posted yet for this study

Summary

The purpose of the study is to quantify the concordance of MPS results between first-catch urine samples collected post-DRE and those collected without a DRE.

Conditions

Interventions

DIAGNOSTIC_TEST

MyProstateScore

MyProstateScore is a urine-based biomarker test used to predict the risk of clinically significant prostate cancer

Sponsors & Collaborators

  • LynxDx

    lead INDUSTRY

Principal Investigators

  • Pratik Patel, MD · Arizona State Urological Institute

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-04-30
Completion
2023-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700370 on ClinicalTrials.gov